IPrAuCl
IPrAuCl (compound 3) is a gold compound. IPrAuCl inhibits sarcoplasmic reticulum Ca2+-ATPase (IC50=16.3 µM) [1].
Product Specifications
CAS Number
852445-83-1
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Calcium Channel
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Field of Research
Cardiovascular Disease
Purity
98.0
Smiles
Cl[Au]C1N(C2=C(C(C)C)C=CC=C2C(C)C)C=CN1C3=C(C(C)C)C=CC=C3C(C)C
Molecular Formula
C27H37AuClN2
Molecular Weight
622.02
Precautions
H315, H319, H335
References & Citations
[1]Fonseca, et al. The Ca2+-ATPase inhibition potential of gold (I, III) compounds. Inorganics 8.9 (2020) : 49.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
R1031-10D1-AP 200 µL
RAGE, CT (Receptor for Advanced Glycosylation End Products, Advanced Glycosylation End Product-specific Receptor, AGER) (AP) discontinued
Sign In for Pricing
View Details 250242 50 µL
PLXDC1 (Plexin Domain Containing 1, DKFZp686F0937, FLJ36270, FLJ45632, TEM3, TEM7)
Sign In for Pricing
View Details 